GSK offloads rights to develop vaccines for Ebola and Marburg viruses (STAT)

More reads

• Mallinckrodt puts off planned generics spinoff amid opioid cases (Bloomberg) 
• Regeneron beats second-quarter profit estimates on Eylea boost (Reuters)
• GSK offloads rights to develop vaccines for Ebola and Marburg viruses (STAT)